Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C001079 |
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
2-(2,6-dioxopiperidin-3-yl)phthalimidine results in decreased expression of ITGA4 protein | decreases expression | 8538367
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in increased expression of ITGA4 mRNA | increases expression | 15982314
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of ITGA4 mRNA | increases expression | 15982314
|
D000499 |
Allylamine |
Allylamine results in decreased expression of ITGA4 mRNA | decreases expression | 15698866
|
D000499 |
Allylamine |
Allylamine results in decreased expression of ITGA4 protein | decreases expression | 15698866
|
D001194 |
Asbestos |
Asbestos affects the expression of ITGA4 mRNA | affects expression | 17297452
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ITGA4 mRNA | increases expression | 15336504
|
D002927 |
Cimetidine |
Cimetidine results in decreased expression of ITGA4 protein | decreases expression | 11556524
|
D003907 |
Dexamethasone |
Dexamethasone results in decreased expression of ITGA4 mRNA | decreases expression | 12782123
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of ITGA4 mRNA | decreases expression | 18042831
|
D017308 |
Etodolac |
Etodolac results in decreased expression of [ITGA4 protein binds to ITGB1 protein] | affects binding|decreases expression | 16046235
|
D005492 |
Folic Acid |
Folic Acid affects the expression of ITGA4 mRNA | affects expression | 17320366
|
C043062 |
N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine |
N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine results in decreased expression of ITGA4 protein | decreases expression | 11556524
|
C041786 |
palm oil |
palm oil results in decreased expression of ITGA4 mRNA | decreases expression | 18042831
|
D015474 |
Isotretinoin |
Isotretinoin results in increased expression of ITGA4 mRNA | increases expression | 15982314
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ITGA4 mRNA | increases expression | 12760830
|
D014212 |
Tretinoin |
Tretinoin metabolite results in increased expression of ITGA4 mRNA | increases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ITGA4 mRNA | increases expression | 15982314
|
D014311 |
Triprolidine |
Triprolidine results in decreased expression of ITGA4 protein | decreases expression | 11556524
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
9.70 | 473085 6734493 3355362 3196154 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
9.70 | 18769834 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.96 | 18769834 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.28 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.48 | 18769834 16185265 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
4.31 | 17003819 16316344 16595132 |
MESH:D000230 |
Adenocarcinoma |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
4.45 | 1933837 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
3.78 | 16963246 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.70 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.90 | 16712894 17306315 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
Etodolac |
5.80 | 16979129 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
3.04 | 17116317 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.87 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
12.56 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
12.56 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.56 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Asbestos |
4.21 | 18795166 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18348195 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.83 | 21388746 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.59 | 16206674 16197459 |
MESH:D001848 |
Bone Diseases, Developmental |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
5.54 | 3355362 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.40 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.40 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
2.40 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine |
2.40 | 18986763 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.40 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.08 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.08 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
10.92 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine |
10.92 | 18986763 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.92 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.92 | 16096774 16051514 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
3.93 | 16755160 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.08 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.97 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.97 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
6.28 | 8946559 21254359 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.28 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
6.39 | 1933837 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.39 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Etodolac |
6.39 | 16004971 |
MESH:D015179 |
Colorectal Neoplasms |
|
Etodolac |
3.49 | 11076880 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
3.49 | 17245555 16985020 17087956 16963246 17116713 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.03 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
4.03 | 9879862 18769834 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.03 | 9142499 16925845 9224671 17551590 8800419 10589399 9125849 9664655 9211117 14991402 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.39 | 12438553 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
3.13 | 16886840 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.68 | 7237001 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.44 | 18367378 |
MESH:D004480 |
Ectromelia |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
7.04 | 7940403 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.44 | 12438553 |
MESH:D004487 |
Edema |
|
Cimetidine |
7.73 | 19703484 |
MESH:D004487 |
Edema |
|
Dexamethasone |
7.73 | 19703484 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.47 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
7.74 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.74 | 16569247 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
5.48 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.56 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.22 | 17967931 19004024 18296743 19551842 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.79 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.79 | 17994277 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
5.09 | 17171786 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.67 | 16452187 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
5.06 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.99 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine |
8.51 | 18986763 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.51 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
7.04 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
7.04 | 9664655 14991402 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.06 | 7520565 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.48 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.13 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.19 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.57 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
4.48 | 16395265 16397167 16865747 16755160 16433478 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.60 | 21332399 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
2.92 | 17042910 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.97 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
5.26 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.26 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.09 | 11836018 18457598 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.88 | 17551590 15992940 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.63 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.79 | 20008137 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.76 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.68 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.14 | 19029980 16788101 16331271 16823087 15748426 17294898 17506722 19075265 16766008 17339181 16140955 17649720 16935935 17712046 17301526 17361223 19225113 19035177 17217047 17107899 17368321 16891316 12679006 19642359 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
2-(2,6-dioxopiperidin-3-yl)phthalimidine |
8.90 | 3355362 6734493 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.90 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.86 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
2.68 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.68 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
3.04 | 16877991 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.36 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.16 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
6.64 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
6.64 | 12111688 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
6.64 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
6.64 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.64 | 15276417 16712894 19931552 17306315 17077188 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.33 | 17718048 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.69 | 16832597 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.24 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.24 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.24 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos |
4.08 | 18709470 16319530 16919927 16564556 18310086 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.49 | 15867202 16118317 15744524 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.50 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.50 | 17596541 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
8.35 | 16946489 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.35 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.35 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.65 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.76 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
12.19 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
12.19 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.19 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
4.03 | 17368321 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
4.49 | 16322990 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.28 | 11836018 19632207 20518802 18674790 21332399 20132043 17217161 18457598 16723640 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.86 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.86 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.88 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.45 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Cimetidine |
5.26 | 10484002 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.00 | 16144296 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.53 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
4.87 | 18769834 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.31 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.91 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
4.76 | 15728788 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.00 | 11700416 18379247 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.08 | 16116481 16283617 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
2.89 | 16641680 |
MESH:D012772 |
Shock, Septic |
|
Triprolidine |
6.21 | 18063050 |
MESH:D012852 |
Sinusitis |
|
Triprolidine |
6.32 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.24 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.46 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.46 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.46 | 16467112 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.48 | 16361298 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.78 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.31 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
2.76 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.76 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.47 | 15138204 |
MESH:D020521 |
Stroke |
|
Folic Acid |
4.31 | 16517955 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.01 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.50 | 17306315 11723127 16452187 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.35 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.35 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.82 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.42 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.72 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |